S&P 500   3,800.62
DOW   30,944.85
QQQ   316.71
S&P 500   3,800.62
DOW   30,944.85
QQQ   316.71
S&P 500   3,800.62
DOW   30,944.85
QQQ   316.71
S&P 500   3,800.62
DOW   30,944.85
QQQ   316.71
Log in

Varian Medical Systems Stock Forecast, Price & News

+0.20 (+0.11 %)
(As of 01/19/2021 03:18 PM ET)
Today's Range
Now: $175.67
50-Day Range
MA: $174.83
52-Week Range
Now: $175.67
Volume3,924 shs
Average Volume641,250 shs
Market Capitalization$16.05 billion
P/E Ratio59.96
Dividend YieldN/A
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Varian Medical Systems logo


Overall MarketRank

1.27 out of 5 stars

Analyst Opinion: 0.8Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment



Sales & Book Value

Annual Sales$3.17 billion
Cash Flow$5.03 per share
Book Value$22.92 per share


Net Income$269.20 million


Market Cap$16.05 billion
Next Earnings Date1/26/2021 (Confirmed)
+0.20 (+0.11 %)
(As of 01/19/2021 03:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

How has Varian Medical Systems' stock price been impacted by Coronavirus?

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VAR stock has increased by 55.4% and is now trading at $175.62.
View which stocks have been most impacted by COVID-19

Is Varian Medical Systems a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 3 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Varian Medical Systems stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VAR, but not buy additional shares or sell existing shares.
View analyst ratings for Varian Medical Systems
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Varian Medical Systems?

Wall Street analysts have given Varian Medical Systems a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Varian Medical Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Tuesday, January 26th 2021.
View our earnings forecast for Varian Medical Systems

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) released its quarterly earnings data on Tuesday, October, 27th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.98 by $0.14. The medical equipment provider had revenue of $850.50 million for the quarter, compared to the consensus estimate of $831.63 million. Varian Medical Systems had a net margin of 8.50% and a return on equity of 18.45%. During the same quarter last year, the business posted $1.21 EPS.
View Varian Medical Systems' earnings history

What price target have analysts set for VAR?

9 analysts have issued 1-year price objectives for Varian Medical Systems' shares. Their forecasts range from $90.00 to $178.00. On average, they expect Varian Medical Systems' stock price to reach $148.28 in the next twelve months. This suggests that the stock has a possible downside of 15.6%.
View analysts' price targets for Varian Medical Systems
or view Wall Street analyst' top-rated stocks.

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), CVS Health (CVS), Gilead Sciences (GILD), Intel (INTC), Visa (V), The Coca-Cola (KO) and AbbVie (ABBV).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the following people:
  • Mr. Dow R. Wilson, CEO & Director (Age 62, Pay $2.45M)
  • Mr. Christopher A. Toth, Pres & COO (Age 42, Pay $972.98k)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 62, Pay $1.45M)
  • Mr. Jesse Michael Bruff, Chief Financial Officer (Age 52)
  • Mr. Magnus A. Momsen, Sr. VP, Chief Accounting Officer & Corp. Controller
  • Mr. Thomas Rodden, Sr. VP & Chief Information Officer
  • Mr. Anshul Maheshwari, VP of Investor Relations & Treasurer
  • Ms. Vy H. Tran, Chief Compliance Officer and Sr. VP of Regulatory Affairs & Quality Assurance (Age 48)
  • Mr. Michael D. Hutchinson, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 50)
  • Mr. Mark Plungy, Director of PR

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.08%), Boston Trust Walden Corp (0.06%), IFM Investors Pty Ltd (0.01%), Thomasville National Bank (0.01%), Louisiana State Employees Retirement System (0.01%) and Private Trust Co. NA (0.00%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin.
View institutional ownership trends for Varian Medical Systems

Which major investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, NuWave Investment Management LLC, State of Alaska Department of Revenue, Private Trust Co. NA, Thomasville National Bank, and Contravisory Investment Management Inc.. Company insiders that have sold Varian Medical Systems company stock in the last year include Dow R Wilson, Kolleen T Kennedy, Magnus Momsen, and R Andrew Eckert.
View insider buying and selling activity for Varian Medical Systems
or view top insider-selling stocks.

Which major investors are buying Varian Medical Systems stock?

VAR stock was purchased by a variety of institutional investors in the last quarter, including IFM Investors Pty Ltd, NBT Bank N A NY, and Louisiana State Employees Retirement System.
View insider buying and selling activity for Varian Medical Systems
or or view top insider-buying stocks.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $175.62.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $16.04 billion and generates $3.17 billion in revenue each year. The medical equipment provider earns $269.20 million in net income (profit) each year or $3.91 on an earnings per share basis. Varian Medical Systems employs 10,000 workers across the globe.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is www.varian.com.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.